Provided by Tiger Fintech (Singapore) Pte. Ltd.

Blueprint Medicines

129.46
0.0000
Volume:- -
Turnover:385.04M
Market Cap:8.38B
PE:-52.77
High:129.46
Open:129.46
Low:129.46
Close:129.46
52wk High:129.65
52wk Low:73.04
Shares:64.73M
Float Shares:60.14M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4532
EPS(LYR):-1.0673
ROE:-47.71%
ROA:-9.75%
PB:24.49
PE(LYR):-121.29

Loading ...

Sanofi sees 'manageable' impact from US tariffs, expects strong sales growth

Reuters
·
Jul 31

BB Biotech AG Reports Q2 2025 Net Loss of CHF 100 Million; USD Share Price Up 10.2%, Currency Drag Impacts CHF Performance

Reuters
·
Jul 25

Sanofi Completes Acquisition Of Blueprint Medicines

Reuters
·
Jul 18

Sanofi SA Acquires Blueprint Medicines, Establishing New Subsidiary Focused on Rare Immunology Diseases

Reuters
·
Jul 18

BRIEF-Sanofi Announces Extension Of Blueprint Tender Offer

Reuters
·
Jul 17

Rothko Merger Sub, Inc., a Sanofi Subsidiary, Extends Tender Offer for Blueprint Medicines

Reuters
·
Jul 17

Christina Rossi, COO, Reports Disposal of Common Shares in Blueprint Medicines Corporation

Reuters
·
Jul 09

Chief Scientific Officer Percy H. Carter Reports Disposal of Common Shares of Blueprint Medicines Corporation

Reuters
·
Jul 09

Blueprint Medicines Corporation Conducted Annual Stockholders Meeting

Reuters
·
Jun 20

Wells Fargo Downgrades Blueprint Medicines to Equalweight From Overweight, Price Target is $129

MT Newswires Live
·
Jun 17

Blueprint Medicines Unveils Promising Long-Term Data for AYVAKIT® in Systemic Mastocytosis at 2025 EHA and EAACI Congresses

Reuters
·
Jun 13

Review -- Barron's

Dow Jones
·
Jun 07

Chief Scientific Officer Percy H. Carter Reports Disposal of Common Shares of Blueprint Medicines Corporation

Reuters
·
Jun 06

BUZZ-U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, Circle

Reuters
·
Jun 06

BUZZ-UBS raises Blueprint Medicines' PT on Sanofi's up to $9.5 billion takeover deal

Reuters
·
Jun 06